Florida Biologix is a Preclinical and Phase I/II biologics contract development, manufacturing, and testing organization focused on a wide range of value-optimizing services, including: cell line engineering, cGMP cell banking, process development, assay development, cGMP vector/protein production in mammalian and insect cells (including monoclonal antibodies, recombinant proteins, enzymes, vaccines, gene transfer vectors, and other biomolecules), cell therapies, purification, aseptic filling (including small molecules, nucleic acids, and proteins), product testing, and regulatory support.